LEADER 05491nam  2200733Ia 450 
001 9910817968803321
005 20240417000856.0
010   $a1-280-20320-X
010   $a9786610203208
010   $a0-309-56189-2
010   $a0-585-02825-7
035   $a(CKB)110986584751170
035   $a(EBL)3377246
035   $a(SSID)ssj0000256498
035   $a(PQKBManifestationID)11193768
035   $a(PQKBTitleCode)TC0000256498
035   $a(PQKBWorkID)10225503
035   $a(PQKB)10617711
035   $a(MiAaPQ)EBC3377246
035   $a(Au-PeEL)EBL3377246
035   $a(CaPaEBR)ebr10068488
035   $a(CaONFJC)MIL20320
035   $a(OCoLC)923269215
035   $a(EXLCZ)99110986584751170
100   $a19920615d1992      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aTechnology and health care in an era of limits /$fAnnetine C. Gelijns, editor ; Committee on Technological Innovation in Medicine, Institute of Medicine
205   $a1st ed.
210   $aWashington, D.C. $cNational Academy Press$d1992
215   $a1 online resource (296 p.)
225 1 $aMedical innovation at the crossroads ;$vv. 3
300   $aPapers presented at the third Institute of Medicine workshop "The Changing Health Care Economy," held April 18-19, 1991, supported by the Howard Hughes Medical Institute, Pfizer, Inc., and the Health Industry Manufacturers Association.
311   $a0-309-04695-5 
320   $aIncludes bibliographical references and index.
327   $a""Technology and Health Care in an Era of Limits""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""List of Abbreviations""; ""Part I Setting the Stage""; ""1 Introduction""; ""References""; ""2 Innovation and the Policies of Limits in a Changing Health Care Economy""; ""THE SHAPE OF MEDICINE'S BENEFIT-UTILIZATION CURVE""; ""WHICH RATE IS RIGHT?""; ""REFORM OF THE DOCTOR-PATIENT RELATIONSHIP""; ""LINKAGE BETWEEN THE SUPPLY OF RESOURCES AND MEDICINE'S IMPLICIT THEORIES OF EFFICACY""; ""SEEKING LIMITS""; ""INNOVATION AND THE POLICIES OF LIMITS""; ""References""
327   $a""Part II Managing Care in the United States""""3 The Growth of Managed Care in the Private Sector""; ""EMPLOYER-PROVIDED HEALTH CARE BENEFITS IN THE UNITED STATES""; ""MANAGED CARE AND ITS GROWTH IN THE PRIVATE SECTOR""; ""IMPLICATIONS OF MANAGED CARE FOR TECHNOLOGY DEVELOPMENT AND DISSEMINATION""; ""References""; ""4 Managing Medical Practice: The Potential of HMOs""; ""MANAGING CARE AT GHC""; ""BREAST CANCER SCREENING""; ""THE HMO AS EFFECTIVENESS LABORATORY""; ""CONCLUSION""; ""References""; ""5 Cost Containment Efforts in the Public Sector: Oregon's Priority List""
327   $a""RATIONALE AND BACKGROUND""""RANKING METHODOLOGY""; ""RESULTS""; ""DISCUSSION""; ""ACKNOWLEDGMENTS""; ""References""; ""Part III Managing Care in the United Kingdom and Canada""; ""6 Priority Setting in a Needs-based System""; ""PROBLEMS OF THE BRITISH HEALTH CARE SYSTEM""; ""THE ""REFORMED"" BRITISH HEALTH CARE SYSTEM""; ""IMPLICATIONS FOR TECHNOLOGICAL ADVANCE IN MEDICINE""; ""RATIONING HEALTH CARE: IS IT ETHICAL?""; ""7 The Meeting of the Twain: Managing Health Care Capital, Capacity, and Costs in Canada""; ""WHAT MAKES CANADIAN HEALTH CARE DIFFERENT?""; ""SO HOW DOES CANADA DO IT?""
327   $a""Managing Operations""""Managing Capital""; ""FROM MACRO- TO MICROMANAGEMENT AND BACK AGAIN?""; ""THE FUTURE OF HEALTH CARE MANAGEMENT IN CANADA""; ""References""; ""Part IV Implications for Providers""; ""8 New Technology Adoption in the Hospital""; ""NEW TECHNOLOGY: WHAT ARE ITS COMPONENTS?""; ""FACTORS INFLUENCING THE ADOPTION AND USE OF TECHNOLOGY""; ""Method of Financing""; ""Recovery of Operating Costs""; ""Regulatory Equity""; ""Level of Competition""; ""Other Factors That Influence the Adoption of New Technology""; ""Hidden New Technology""; ""SUMMARY""; ""REFERENCES""
327   $a""9 Physicians' Acquisition and Use of New Technology in an Era of Economic Constraints""""DIFFUSION OF MAGNETIC RESONANCE IMAGING INTO CLINICAL PRACTICE""; ""Regulation of Magnetic Resonance Imaging Acquisition""; ""The Food and Drug Administration""; ""Certificate of Need Regulations""; ""Reimbursement for Magnetic Resonance Imaging""; ""Competition Over Magnetic Resonance Imaging""; ""Summary: The Acquisition of Magnetic Resonance Imaging""; ""TECHNOLOGY ACQUISITION IN THE ""NEW HEALTH CARE"" ERA""; ""Nature of Technology""; ""Hospitals and Regulation""; ""Competition for Patients""
327   $a""Reimbursement""
410  0$aMedical innovation at the crossroads ;$vv. 3.
606   $aManaged care plans (Medical care)$vCongresses
606   $aMedical care$zUnited States$vCongresses
606   $aMedical technology$xEffect of managed care on$zUnited States
615  0$aManaged care plans (Medical care)
615  0$aMedical care
615  0$aMedical technology$xEffect of managed care on
676   $a362.1
701   $aGelijns$b Annetine$01640409
712 02$aInstitute of Medicine (U.S.).$bCommittee on Technological Innovation in Medicine.
712 02$aHoward Hughes Medical Institute.
712 02$aPfizer Inc.
712 02$aHealth Industry Manufacturers Association.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910817968803321
996   $aTechnology and health care in an era of limits$94006839
997   $aUNINA